Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 68

    1.

    Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.

    Riddle MC.

    Diabetes Care. 2008 Feb;31 Suppl 2:S125-30. No abstract available. PMID: 18227472 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

    Origin Trial Investigators, Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J.

    Am Heart J. 2008 Jan;155(1):26-32, 32.e1-6. Epub 2007 Nov 26.PMID: 18082485 [PubMed - indexed for MEDLINE]Related articles

    3.

    Starting and advancing insulin for type 2 diabetes: algorithms and individualized methods are both necessary.

    Riddle MC.

    J Clin Endocrinol Metab. 2008 Feb;93(2):372-4. Epub 2007 Dec 11. No abstract available. PMID: 18073293 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

    Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P; ACCORD Study Group.

    Am J Cardiol. 2007 Jun 18;99(12A):34i-43i. Epub 2007 Apr 19.PMID: 17599423 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is initial combination therapy effective in the treatment of type 2 diabetes?

    Riddle MC.

    Nat Clin Pract Endocrinol Metab. 2006 May;2(5):254-5. No abstract available. PMID: 16932294 [PubMed]Related articles

    7.

    Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.

    Riddle MC, Henry RR, Poon TH, Zhang B, Mac SM, Holcombe JH, Kim DD, Maggs DG.

    Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):483-91.PMID: 16634116 [PubMed - indexed for MEDLINE]Related articles

    8.

    The Treat-to-Target Trial and related studies.

    Riddle MC.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:71-9.PMID: 16627386 [PubMed - indexed for MEDLINE]Related articles

    9.

    ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations.

    Lebovitz HE, Austin MM, Blonde L, Davidson JA, Del Prato S, Gavin JR 3rd, Handelsman Y, Jellinger PS, Levy P, Riddle MC, Roberts VL, Siminerio LM; ACE/AACE Diabetes Recommendations Implementation Writing Committee.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:6-12. No abstract available. PMID: 16627372 [PubMed - indexed for MEDLINE]Related articles

    10.

    Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.

    Riddle MC, Drucker DJ.

    Diabetes Care. 2006 Feb;29(2):435-49. Review. No abstract available. PMID: 16443905 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

    Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD.

    Diabetes Care. 2005 May;28(5):1083-91.PMID: 15855571 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Making the transition from oral to insulin therapy.

    Riddle MC.

    Am J Med. 2005 May;118 Suppl 5A:14S-20S. Review.PMID: 15850549 [PubMed - indexed for MEDLINE]Related articles

    13.

    Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations.

    Riddle MC.

    Endocrinol Metab Clin North Am. 2005 Mar;34(1):77-98. Review.PMID: 15752923 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

    Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H.

    Diabetes Care. 2005 Feb;28(2):254-9.PMID: 15677775 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Timely initiation of basal insulin.

    Riddle MC.

    Am J Med. 2004 Feb 2;116 Suppl 3A:3S-9S. Review.PMID: 15013454 [PubMed - indexed for MEDLINE]Related articles

    16.

    Type 2 diabetes: the role of basal insulin therapy.

    LeRoith D, Levetan CS, Hirsch IB, Riddle MC.

    J Fam Pract. 2004 Mar;53(3):215-22. No abstract available. PMID: 15000929 [PubMed - indexed for MEDLINE]Related articles

    17.

    What to do when two oral agents fail to control type 2 diabetes--a matter of opinion or a matter of fact?

    Ahmann AJ, Riddle MC.

    Am J Med. 2004 Feb 15;116(4):276-8. No abstract available. PMID: 14969657 [PubMed - indexed for MEDLINE]Related articles

    18.

    The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

    Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators.

    Diabetes Care. 2003 Nov;26(11):3080-6.PMID: 14578243 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?

    Riddle MC.

    J Clin Endocrinol Metab. 2003 Feb;88(2):528-30. Review. No abstract available. PMID: 12574174 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The underuse of insulin therapy in North America.

    Riddle MC.

    Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S42-9. Review.PMID: 12324985 [PubMed - indexed for MEDLINE]Related articles

    21.

    Current oral agents for type 2 diabetes. Many options, but which to choose when?

    Ahmann AJ, Riddle MC.

    Postgrad Med. 2002 May;111(5):32-4, 37-40, 43-6. Review.PMID: 12040862 [PubMed - indexed for MEDLINE]Related articles

    22.

    Pramlintide: an agent for glycemic control plus weight control?

    Riddle MC.

    Diabetes Technol Ther. 2002;4(1):63-5. No abstract available. PMID: 12017422 [PubMed - indexed for MEDLINE]Related articles

    23.

    Timely addition of insulin to oral therapy for type 2 diabetes.

    Riddle MC.

    Diabetes Care. 2002 Feb;25(2):395-6. Review. No abstract available. PMID: 11815517 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Measuring fructosamine at home.

    Riddle MC.

    Diabetes Technol Ther. 2000 Summer;2(2):239-40. No abstract available. PMID: 11469265 [PubMed - indexed for MEDLINE]Related articles

    25.

    A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.

    Raskin P, Rendell M, Riddle MC, Dole JF, Freed MI, Rosenstock J; Rosiglitazone Clinical Trials Study Group.

    Diabetes Care. 2001 Jul;24(7):1226-32.PMID: 11423507 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Oral pharmacologic management of type 2 diabetes.

    Riddle MC.

    Am Fam Physician. 1999 Dec;60(9):2613-20. Review.PMID: 10605995 [PubMed - indexed for MEDLINE]Related articles

    27.

    Overview of current therapeutic options: session summary.

    Riddle MC.

    Diabetes Care. 1999 Apr;22 Suppl 3:C76-8. No abstract available. PMID: 10375292 [PubMed - indexed for MEDLINE]Related articles

    28.

    Learning to use troglitazone.

    Riddle MC.

    Diabetes Care. 1998 Sep;21(9):1389-90. Review. No abstract available. PMID: 9727881 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Insulin treatment for type 2 diabetes.

    Riddle MC, Karl DM.

    JAMA. 1998 May 20;279(19):1523; author reply 1525-6. No abstract available. PMID: 9605886 [PubMed - indexed for MEDLINE]Related articles

    31.

    Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office.

    Glasgow RE, La Chance PA, Toobert DJ, Brown J, Hampson SE, Riddle MC.

    Patient Educ Couns. 1997 Nov;32(3):175-84.PMID: 9423499 [PubMed - indexed for MEDLINE]Related articles

    32.

    Tactics for type II diabetes.

    Riddle MC.

    Endocrinol Metab Clin North Am. 1997 Sep;26(3):659-77. Review.PMID: 9314021 [PubMed - indexed for MEDLINE]Related articles

    33.

    Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM.

    Riddle MC, McDaniel PA, Tive LA.

    Diabetes Care. 1997 Jun;20(6):992-4.PMID: 9167112 [PubMed - indexed for MEDLINE]Related articles

    34.

    Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.

    Riddle MC.

    Horm Metab Res. 1996 Sep;28(9):430-3. Review.PMID: 8911978 [PubMed - indexed for MEDLINE]Related articles

    35.

    Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.

    Riddle MC, McDaniel PA.

    J Clin Endocrinol Metab. 1994 Apr;78(4):830-4.PMID: 8157707 [PubMed - indexed for MEDLINE]Related articles

    36.

    Acute reduction of renal 11 beta-hydroxysteroid dehydrogenase activity by several antinatriuretic stimuli.

    Riddle MC, McDaniel PA.

    Metabolism. 1993 Oct;42(10):1370-4.PMID: 8412753 [PubMed - indexed for MEDLINE]Related articles

    37.

    Different takes on the relationship of insulin treatment to blood pressure.

    Riddle MC.

    Diabetes Care. 1993 Jun;16(6):953-4; commentary 954-5. No abstract available. PMID: 8325217 [PubMed - indexed for MEDLINE]Related articles

    38.

    Strategies for non-insulin-dependent diabetes mellitus.

    Riddle MC.

    Hosp Pract (Off Ed). 1993 Apr 30;28(4A):14, 17-8, 20. No abstract available. PMID: 8473365 [PubMed - indexed for MEDLINE]Related articles

    39.

    Combining insulin and sulfonylurea. A therapeutic option for type II diabetes.

    Riddle MC.

    Postgrad Med. 1992 Aug;92(2):89-90, 95-6, 99-102.PMID: 1495886 [PubMed - indexed for MEDLINE]Related articles

    40.

    A model for the apparent decrease in optical transmittance of the diabetic eye.

    Daley ML, Watzke RC, Riddle MC.

    IEEE Trans Biomed Eng. 1992 Jan;39(1):88-94.PMID: 1572686 [PubMed - indexed for MEDLINE]Related articles

    41.

    Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.

    Riddle MC.

    Diabetes Res Clin Pract. 1991 Jan;11(1):3-8. Review. No abstract available. PMID: 2019232 [PubMed - indexed for MEDLINE]Related articles

    42.

    Diabetic neuropathies in the elderly: management update.

    Riddle MC.

    Geriatrics. 1990 Sep;45(9):32-6. Review.PMID: 2204585 [PubMed - indexed for MEDLINE]Related articles

    43.

    Evening insulin strategy.

    Riddle MC.

    Diabetes Care. 1990 Jun;13(6):676-86. Review.PMID: 2192851 [PubMed - indexed for MEDLINE]Related articles

    44.

    The mental efficiency of the elderly person with type II diabetes mellitus.

    U'Ren RC, Riddle MC, Lezak MD, Bennington-Davis M.

    J Am Geriatr Soc. 1990 May;38(5):505-10.PMID: 2332570 [PubMed - indexed for MEDLINE]Related articles

    45.

    Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

    Riddle MC, Hart JS, Bouma DJ, Phillipson BE, Youker G.

    Diabetes Care. 1989 Oct;12(9):623-9.PMID: 2507265 [PubMed - indexed for MEDLINE]Related articles

    46.

    Combined insulin-sulfonylurea treatment of type II diabetes.

    Bingham PR, Riddle MC.

    Diabetes Educ. 1989 Sep-Oct;15(5):450-5. Review.PMID: 2673707 [PubMed - indexed for MEDLINE]Related articles

    47.

    Influence of selective protein deprivation on rat adipose tissue cellularity and lipolysis in isolated adipocytes.

    Khardori R, Riddle MC, Stephens JW.

    Indian J Exp Biol. 1988 Feb;26(2):129-32. No abstract available. PMID: 3397110 [PubMed - indexed for MEDLINE]Related articles

    48.

    Early loss of blue-sensitive color vision in patients with type I diabetes.

    Daley ML, Watzke RC, Riddle MC.

    Diabetes Care. 1987 Nov-Dec;10(6):777-81.PMID: 3501362 [PubMed - indexed for MEDLINE]Related articles

    49.

    More on syringe reuse.

    Borders LM, Bingham PR, Riddle MC.

    Diabetes Care. 1985 Nov-Dec;8(6):626-7. No abstract available. PMID: 3908031 [PubMed - indexed for MEDLINE]Related articles

    50.

    The effects of a high-carbohydrate low-fat cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type I) diabetes mellitus.

    Hollenbeck CB, Connor WE, Riddle MC, Alaupovic P, Leklem JE.

    Metabolism. 1985 Jun;34(6):559-66.PMID: 3999978 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...